Medistim ASA (LON:0OCD)

Market Cap	308.33M +36.9%
Revenue (ttm)	51.58M +25.8%
Net Income	11.73M +53.3%
EPS	0.64 +53.6%
Shares Out	n/a
PE Ratio	26.28
Forward PE	25.36
Dividend	0.44 (0.21%)
Ex-Dividend Date	May 9, 2025

Volume	1,650
Average Volume	2,242
Open	208.00
Previous Close	211.00
Day's Range	208.00 - 208.00
52-Week Range	160.50 - 288.00
Beta	1.06
RSI	45.79
Earnings Date	Feb 27, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0OCD

Financial Performance

In 2025, Medistim ASA's revenue was 699.77 million, an increase of 25.82% compared to the previous year's 556.16 million. Earnings were 159.21 million, an increase of 53.33%.

Financial numbers in NOK